PREGNANCY AND BREASTFEEDING SAFETY:
- There are no adequate studies of fluvoxamine in pregnant women. Infants exposed to SSRIs in late pregnancy may have an increased risk for persistent pulmonary hypertension of the newborn (PPHN), which can be fatal.
- Fluvoxamine is excreted into breast milk. There are no adequate studies in lactating women.
STORAGE: Tablets should be kept at room temperature, 15 C - 30 C (59 F - 86 F).
- The usual starting dose for adults is 50 mg daily given as a single dose at bedtime.
- The dose may be increased in 50 mg increments every 4-7 days to achieve the desired response.
- The maximum dose is 300 mg/day. Doses greater than 100 mg should be administered as a divided dose.
- When using extended release tablets the starting dose is 100 mg at bedtime and the maximum dose is 300 mg.
- Children (8 to 17 years old) should start with 25 mg daily given at bedtime, and the dose may be increased by 25 mg every 4-7 days up to a maximum of 200 mg/day (8-11 years old) or 300 mg/day (12-17 years old). Doses greater than 50 mg should be administered as a divided dose.
Quick GuideDepression Hurts: Physical Symptoms of Depression
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.